Mu opioid receptor mRNA overexpression predicts poor prognosis among 18 common solid cancers: A pan-cancer analysis

BACKGROUND: Opioids are widely used for patients with solid tumors during surgery and for cancer pain relief. We conducted a pan-cancer genomic analysis to investigate the prognostic features of Mu opioid receptor (MOR) mRNA expression across 18 primary solid cancers. METHODS: All the data of cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Wei, Zhuang, Shaohui, Cheng, Minghua, Qiu, Zeting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10098160/
https://www.ncbi.nlm.nih.gov/pubmed/37064155
http://dx.doi.org/10.3389/fonc.2023.1134744

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10098160/
https://www.ncbi.nlm.nih.gov/pubmed/37064155
http://dx.doi.org/10.3389/fonc.2023.1134744

Ejemplares similares